INTECH Investment Management
ABOS icon

INTECH Investment Management’s Acumen Pharmaceuticals ABOS Stock Holding History

INTECH Investment Management’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,446
Closed -$27.9K – 1231
2026
Q2 		$27.9K Buy
+10,446
New +$25.8K ﹤0.01% 2096
2025
Q2 		– Sell
-28,540
Closed -$31.4K – 2448
2025
Q1 		$31.4K Buy
28,540
+9,693
+51% +$13.8K ﹤0.01% 2478
2024
Q4 		$32.4K Buy
+18,847
New +$45.4K ﹤0.01% 2361

Other funds holding ABOS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Catalyst Financial Partners
Catalyst Financial Partners Boston, Massachusetts $1.07B AUM 26.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

INTECH Investment Management's ABOS Position: Q3 2026 in Review

INTECH Investment Management sold out of Acumen Pharmaceuticals (ABOS) in Q3 2026, closing a stake of 10,446 shares — an estimated $27.9K sold.

INTECH Investment Management first reported a position in ABOS in Q4 2024 and held it in 3 quarters. The position peaked at $32.4K in Q4 2024. 37 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.

  • INTECH Investment Management reported no remaining Acumen Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • INTECH Investment Management sold 10,446 Acumen Pharmaceuticals shares in Q3 2026, an estimated $27.9K.
  • INTECH Investment Management first reported a position in Acumen Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • INTECH Investment Management's Acumen Pharmaceuticals position peaked at $32.4K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.

Based on INTECH Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.